Introduction Decision-analytic models play an essential role in informing healthcare resource allocation decisions; however, their value to decision makers will depend on model structures being clinically valid to determine cost-effectiveness recommendations. Clinician involvement can help modellers to develop clinically valid but straightforward structures; however, there is little guidance available on methods for clinician input to model structure. This study aims to provide an in-depth exploration of clinician involvement in structural development, highlighting key issues and generating recommendations to optimise practices. Methods A qualitative study was undertaken with a range of modellers and clinicians working in different modelling contexts. In-depth interviews and case studies using observations were carried out to understand how clinicians are involved in model structural development and to identify problems and optimal approaches from informants' perspectives. Results Twenty-four interviews and two case studies were undertaken with modellers and modelling teams. Key issues included the number and diversity of clinicians contributing to structural development, potentially impacting the generalisability of structures, and problems with clinician understanding of important information to contribute to model pathways. Modellers and clinicians suggested that clinician training in modelling could enhance structural processes. Conclusions Recommendations to optimise current practices include recruiting clinicians from a variety of backgrounds and using discussions between experts to develop valid and generalisable structures. Future research should focus on developing training materials for clinicians and finding ways to help modellers recruit clinicians from different settings.
Introduction
Decision-analytic models play a key role in informing health technology assessment (HTA) and resource allocation decisions [1, 2] . Models provide a vehicle for economic evaluation and cost-effectiveness analysis, where the focus is on establishing incremental costs and consequences of competing interventions to inform decision making [3] . An essential aspect of developing a model is ensuring that it is clinically valid and reflects real life, but also that it is straightforward to its users [4] . Model structures can therefore be more simplistic than the 'real world'. The pathways or states contained in model structure should reflect the disease natural history [5] [6] [7] [8] but also prioritise events where differences in the costs and outcomes between competing interventions are expected, and events that are likely to impact the model output [9, 10] . Consulting with clinicians can help modellers to build straightforward but valid structures and ensure important events are captured. However, little guidance exists on clinician input to structural development, with current guidelines suggesting that clinicians should be consulted, but offering limited insight into how this works in practice [8] . A recent synthesis of modelling guidelines ignored clinician involvement in structural development entirely [11] .
The benefits of using qualitative research to explore modelling activities have been advocated, with a view to using findings to make improvements to modelling practices [12] . A small number of empirical studies have used qualitative methods to generate recommendations for model building, looking at clinician involvement in structural development as part of broader research [13] [14] [15] . Recommendations from these studies emphasised the importance of using clinical input to translate the disease area/decision problem into model structure, and for structural validation. These papers suggested that clinicians should be involved early in structural development [15] and recommended the input of large numbers of clinicians [8] and clinicians from different backgrounds [13] . Two papers suggested methods for facilitating communication between modellers and clinicians, specifically non-technical terminology and structural diagrams to aid discussions [13, 14] . Although these recommendations are valuable, there has been no focused research to understand current practice and key issues with clinician involvement in structural development.
This paper presents findings from a research study using in-depth qualitative methods to explore clinician involvement in structural development, aiming to highlight good practice and important areas for future research. Model structure is defined here as the representation of the health and economic consequences occurring when patient populations receive particular medical interventions [16] .
Methods

Overview
This research used two phases of qualitative study to investigate clinician involvement in structural development from the perspectives of those involved [17] . In-depth interviews were used in the first phase to gather rich accounts of modellers' processes for involving clinical experts [18] . The second phase used case study methods, specifically nonparticipant observation and semi-structured interviews, to gain comprehensive insight into structural development as it occurred [19] . Whilst observations demonstrated how modelling teams were involving clinicians, interviews captured reflections of informants on methods used. Both phases of the research were used together to generate key findings.
Sampling
Modellers for in-depth interviews were sampled using purposive sampling, which focuses on the views of those able to provide in-depth knowledge of the topic of interest [19] . Sampling also aimed to capture variation in breadth of modeller experience, from two settings where economic modelling is integral to HTA: UK and Canada [20, 21] . Modellers approached included those working in academia, industry (for consultancies/pharmaceutical companies), and policy (institutes). The seniority of an informant (level of experience) was judged according to whether modellers worked mostly in a managerial capacity (senior) or on hands-on model development (junior). Snowball sampling, where existing informants suggest others to contribute to the research, provided access to non-academic and international informants [22] . Sampling continued until saturation, where no new insights were emerging from continued interviews [23] .
Sampling for case studies involved selecting modelling teams to observe throughout a single model's development, involving those who could provide potentially different insights to enhance transferability of findings [24] . Sampling focused on teams who had a good reputation in model building and from whom we could make inferences about good modelling practices, which would be helpful to other modellers and settings [25] . Phase 1 informants were asked to recommend modelling teams who met these criteria, and a sub-sample were approached by the authors.
Data Collection
In-depth interviews were conducted face to face [26] . Interviews followed a topic guide (see Appendix 1 in the electronic supplementary material), which was updated as new themes emerged. Open-ended, responsive questioning was adopted [27] .
Case study observation was undertaken of all face-to-face meetings and emails, and semi-structured interviews were conducted with modellers and clinicians at various time points throughout structural development. Most interviews were faceto-face, but some with clinicians were over the telephone. A topic guide was used, which included general questions and those specific to the context observed.
Meetings were audio-recorded, and notes were taken to report the primary author's perceptions and thoughts [28] . Interviews in both phases were audio-recorded.
Data Analysis
In-depth interviews were analysed by SH using methods of constant comparison, which requires new data to be continually compared with existing data to enhance understanding and develop key themes [29] . Interview transcripts were coded line by line, and data were organised into themes and assigned a representative code [30] . Analysis was undertaken for batches of interviews, and a coding structure was developed and applied to all transcripts, with codes continually updated for new data. Analytic accounts were created for each batch of interviews to compare informants' comments, and later combined. A sub-sample of transcripts was double-coded by JC.
Case study data were analysed using Framework analysis, a matrix based analytic method where individual informants' data (for example, excerpts from interviews) are charted and organised into shared themes to synthesise findings [31] . Analysis began with a review of data, and notes were taken of important and recurrent themes to generate a thematic framework [31] . This framework was applied to all case study materials and refined as themes emerged. Data were coded by line or passage using a qualitative software package, NVivo10. Charts were created for each case study to organise excerpts from data collection according to key themes and the method by which they were generated.
In presenting findings, all informants have been assigned identifiers starting "M" to indicate a modeller and "C" a clinician; clinical details of modelling activities are anonymised. The findings have been synthesised under four overarching themes which combine findings from both research phases: recruiting clinicians, number and background of clinicians, problems with clinician involvement and enhancing clinician involvement.
Results
Informant Characteristics
For phase 1, 24 in-depth interviews were undertaken with a range of modellers, with varying experience noted within senior and junior groups (Table 1) .
For phase 2, two case studies were undertaken. Case study A (CSA) was within a UK university, with a junior and senior modeller and one clinician (C1) involved in the primary team. C1 was the chief investigator (CI) and was a specialist consultant with over 10 years' experience working for the National Health Service (NHS). C1 had no previous experience of modelling. The model received ad hoc input from another modeller and a wider group of clinical collaborators and statisticians. Case study B (CSB) was in a UK policy institute, and the modelling team included a junior and senior modeller and up to 11 clinical experts per meeting. The backgrounds of clinicians recruited to CSB varied in geographical area and clinical role. A subset of three clinicians were sampled for interview (C2-C4). All had worked for NHS hospitals and had over 10 years' experience as a consultant in their respective specialisms. All also had some previous experience of health economics, with C3 having input to other models and C2 and C4 having worked on research projects with a cost-effectiveness element. Other members of the modelling team included information specialists, systematic reviewers and project managers. See Table 2 for case study characteristics. Table 3 contains a summary of the results.
Recruiting Clinicians for Structural Development
Modellers interviewed in phase 1 discussed clinician recruitment, with a common scenario for UK academic modellers, and CSA, being that clinicians were CIs or co-applicants on a project requiring modelling expertise. The industry and policy modellers interviewed (including CSB) mostly reported recruiting clinicians to their own model-based projects, citing formal and established methods for doing so (including links through model clients and via public advertisements). However, the remaining academic modellers (UK and Canadian) described informal processes for recruitment, such as cold calling and pursuing links through colleagues. These modellers indicated that they had difficulty engaging clinicians, particularly when relying on clinicians for ad hoc input:
M4 (interview, phase 1): "[I]t's often quite difficult to get a clinician's time…if they have a lot of clinical time with patients it's almost impossible…"
In terms of a clinicians' role, there was consensus across interviews and case studies that clinician input was required to inform model clinical pathways, and emphasis from some modellers around the importance of clinicians agreeing on a final version of structure prior to running the model: M24 (interview, phase 1): "I don't do too much on [validation of] structure…if I've got sign off from the clinician…"
Number and Background of Clinicians
Numbers of clinicians involved in structural development varied for interview informants (Table 4) , as they discussed involving between zero and 12, with the most common scenario being two, but a quarter of informants discussing working with one. CSA and CSB involved one and up to 11 clinicians, respectively. Numbers differed as those working in industry and policy involved greater numbers than those in academia, potentially due to different strategies for recruitment. Modellers suggested numbers could vary between projects and according to disease complexity and variation in healthcare practices: 
Problems with Clinician Involvement
Clinician Numbers
Although a quarter of modellers described instances of involving one clinician in structural development, modellers' general opinion was that this would limit structural generalisability: However, there were a small number of modellers who discussed problems with involving larger groups in structural development, specifically managing and incorporating multiple perspectives: M17 (interview, phase 1): "[T]hings quickly get complicated because you end up with eight clinicians who have eight different views…and end up with an overelaborate model…"
The issue of generalisability of clinician experience was rarely acknowledged, with only one interview informant (M8) and one case study (CSB) having discussed or observed recruiting clinicians from a range of backgrounds:
M8 (interview, phase 1): "[A]n A and E nurse, a consultant…a surgeon…we try to get a big range of clinicians involved with the pathway…"
Clinician Understanding
Most interview informants reported problems with receiving information from clinicians, as clinicians focused on the experiences of individuals rather than groups of patients when informing structural pathways: M11 (interview, phase 1): "[T]his concept of 'we are massively oversimplifying what happens in this disease and we're assuming every patient is the same', that's quite difficult for clinicians". M14 (interview, phase 1): "[T]he hard thing with clinicians is getting them to abstract because they see individuals, they don't see a group".
Many interview informants also commented on the tendency of clinicians to highlight uncommon and unrepresentative patient experiences when suggesting health states/pathways to include: M4 (interview, phase 1): "[T]hey'll talk about really rare events…that in their thirty years of experience they've witnessed once, and they'll suggest you put this in…" Similar tensions were observed within CSA, as C1 suggested that the experiences of a rare patient group should be incorporated, with the modeller conversely suggesting that this population should be excluded for not representing a common group:
Observation, CSA:
C1: "Include them…in the last six years…I have only seen one a year where they've had [Problem 3] and they've had [Major surgery], they're a small proportion…" M26: "[W]e just want to be trundling along as if most people are the general case…although you've said include them I think we mean exclude them, because they're such a minority…"
However, a contrasting situation was observed in CSB, as clinicians appeared to consider it inappropriate to include a rarer clinical event in the structure due to lack of available evidence. The modeller subsequently implies that this event should be included because it is economically important and may impact the cost-effectiveness analysis:
Observation, CSB: 
Enhancing Clinician Involvement: Recommendations Emerging from the Research
Optimum Number
Observations from CSB suggested that discussions between multiple clinicians were valuable for identifying common and representative structural pathways, avoiding the generalisability issues observed with one clinician in CSA: Observation, CSB: Comments from clinicians in CSB advocated involving larger numbers and a diversity of clinical expertise, with discussions leading to increased confidence in the clinical validity and structural generalisability of model results: C2 (interview, CSB): "It's clear from discussions around the table that things are very different across the country and …it's…really important…in terms of validating the outcome…the strength and breadth of experience and geography of clinicians". C3 (interview, CSB): "If there are issues that you haven't considered as a group that are pointed out after [the model has been published] it would undermine credibility…it's important to have these discussions".
Clinician Training
Several modellers suggested offering clinicians training in structural development to enhance efficiency of structural processes, advocating the value of providing clinicians with information about clinically and economically important pathways/states to communicate: 
Discussion
Key Findings
This research has provided detailed insight into clinician involvement in structural development, highlighting key issues around clinician recruitment, numbers and generalisability, and clinician understanding. Information was collected on numbers and backgrounds of clinicians involved in current processes, demonstrating the average number to be two, but highlighting the experiences of several modellers who had involved only one. This included the observation of a single clinician in CSA, who struggled to decide on representative clinical pathways to inform model structure. Only one of the case studies and one modeller interviewed discussed recruiting clinicians from different clinical/geographical backgrounds. These findings raise issues around the generalisability of model structures, particularly when compared to approaches used to elicit evidence parameter values from experts, as these studies recruit/recommend greater numbers and varied samples of clinicians to reflect differences in clinical practices and avoid bias [32, 33] . Further, several modellers in this research discussed being approached for participation by clinicians with existing projects (academic modellers) or using established contacts to recruit experts (industry modellers), with emphasis on speaking to leading and senior clinicians. However, this approach could potentially lead to bias in similar groups of clinicians continually being asked to contribute, and the under representation of experiences of lesser known and junior clinicians.
Modellers reported and were observed having difficulties with retrieving required information from clinicians, as clinicians were unaware of the importance of including events in the structure which are likely to impact cost-effectiveness. Clinicians had problems understanding how model structures were developed and with interpreting the economic and research terminology used, with clinicians and modellers supporting training for clinicians. Although we have not identified any studies advocating clinician training in structural development, its importance has been emphasised in the expert elicitation literature, suggesting that experts will give more confident and accurate answers if they know the purpose and processes behind the tasks they are given [32] .
These findings collectively support the value of recommendations to enhance clinician involvement in structural development.
Strengths and Limitations
This research extends insight into clinician involvement in structural development significantly, based on in-depth qualitative study with a broad sample of modellers. Although there were synergies between the findings generated and those of similar studies, including the importance of effective communication and varied clinical perspectives [13] [14] [15] , issues around generalisability and the importance of clinician training have not previously been emphasised. A comprehensive sampling strategy was employed to include the perspectives of a range of modellers to ensure findings from this research could be generalisable to multiple modelling contexts and relevant to a variety of modellers. The research also includes the perspectives of clinicians on structural development, which have not been investigated previously.
The work was limited by only having resources to conduct two case studies, both in the UK setting. Although the case study research was extensive, further work could benefit from widening the case studies to explore models conducted within industry, in other country settings or with smaller/ lesser known modelling teams. It is possible that the work is also less relevant for those working outside of the UK and Canada, where modelling practices may be different. Greater insight may have been permitted from further clinician interviews, as sampling was limited by the availability of clinicians in each case study, and it may be that their views and experiences are not representative of all clinical experts. Nevertheless, in-depth qualitative methods have allowed detailed and novel insights to emerge, including through observation of communication between modellers and clinicians. Such an extensive investigation of real structural development processes has resulted in recommendations focusing on issues reported and observed to be most pertinent to those developing models [12] .
Recommendations for Practice and Future Research
Findings suggest that a purposeful approach to sampling clinicians for structural development is optimal, aiming to achieve maximum variation in clinicians' backgrounds relevant to the modelling context [34] . Sampling therefore focuses on the diversity of experts' experiences, rather than maximising numbers, aligning with recommendations from expert elicitation studies [32, 33, 35] and acknowledging the recruitment difficulties reported. Modellers should make efforts to sample junior clinicians and those working outside of leading centres and professional links, to avoid correlation in clinicians' views and to account for potentially different perspectives. The practicality of sampling clinicians outside of typical avenues is an important consideration for future research. Discussions between clinicians were observed to be valuable in identifying representative model pathways, and as such modelling processes may benefit from structured methods for gathering and managing multiple clinician perspectives. Possible approaches include qualitative focus groups [12] and the nominal group technique [32] , which are both overseen by a moderator to avoid dominance and bias, and encourage individuals to reach consensus through consideration of each other's views. The development of clinician training is an important area for future work, requiring further research to generate and evaluate 'universal' training content, with emphasis on the issues identified as important for guidance here. However, it is perhaps also worth considering the value of educating modellers in how to optimally present and gather information from clinical experts. Where time is limited, structural development may still benefit from modellers providing clinicians with a short history of decision-analytic modelling, explaining how structural pathways differ from clinical practice and providing regular updates on structural development using diagrams.
It would be interesting to conduct further case studies to explore structural development in models where there are strong clinical advocates for the alternatives; where biases in pathway development may arise. Another important area for empirical research is exploring the methods and approaches modellers are using to elicit and aggregate quantitative evidence parameters from clinicians in practice [35] . More broadly, qualitative research could explore other structural questions, such as how modellers incorporate clinicians' views alongside information from other sources, including literature, other models and data availability.
Conclusions
This qualitative study has provided detailed insight into clinician involvement in structural development, highlighting key issues from modeller and clinician perspectives. Recommendations for modellers include recruiting clinicians from diverse backgrounds to encourage generalisable structures, and facilitating discussions between clinicians to generate robust and representative structural pathways. Future research should focus on clinician training to enhance efficiency of structural development processes, and investigate strategies for sampling clinicians outside of typical approaches. Steps to optimise clinician involvement can enhance the clinical validity of model structures and increase confidence in the decisions models inform.
